Clinical Trials
12 trialsNCT02232516 2024-04-10
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
Northwestern University
Phase 2 Unknown
NCT06037239 2023-09-14
Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study
Peking Union Medical College Hospital
Phase 1/2 Unknown
NCT03646422 2022-03-31
AEDV Registry of Primary Cutaneous Lymphoma
Fundación Academia Española de Dermatología
Unknown
NCT04296786 2020-03-05
Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03920696 2019-04-19
EtudePL
Assistance Publique - Hôpitaux de Paris
Unknown
NCT03822988 2019-01-30
PADAONCODERM
Central Hospital, Nancy, France
Unknown
NCT03340155 2017-11-13
BioUV2017
Medical University of Graz
Phase NA Unknown
NCT02881749 2016-08-30
Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides
Thomas Jefferson University
Phase 2 Unknown
NCT02539472 2016-04-18
DIAPREMYF
Assistance Publique - Hôpitaux de Paris
Phase NA Unknown
NCT02039895 2014-08-04
HITS
Far Eastern Memorial Hospital
Phase NA Unknown
NCT01132989 2010-05-28
REvMM2009
Florida Academic Dermatology Centers
Phase 2 Unknown
NCT00779896 2008-10-24
Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study
McGill University
Phase 1/2 Unknown